Invention Grant
- Patent Title: Composition comprising aflibercept, folinic acid, 5-fluorouracil (5-FU) and irinotecan (FOLFIRI)
-
Application No.: US14113757Application Date: 2012-04-25
-
Publication No.: US11033606B2Publication Date: 2021-06-15
- Inventor: Remi Castan
- Applicant: Remi Castan
- Applicant Address: FR Paris
- Assignee: Remi Castan
- Current Assignee: Remi Castan
- Current Assignee Address: FR Paris
- Agency: Lathrop GPM LLP
- Agent James H. Velema; Judith L. Stone-Hulslander
- Priority: EP1305490 20110426,EP1306154 20110915
- International Application: PCT/EP2012/057542 WO 20120425
- International Announcement: WO2012/146610 WO 20121101
- Main IPC: A61K38/17
- IPC: A61K38/17 ; A61P35/00 ; A61K31/4745 ; A61K31/513 ; A61K31/519 ; A61K9/00 ; A61K38/00
Abstract:
Pharmaceutical composition comprising aflibercept, folinic acid, 5-fluorouracil (5-FU) and irinocetan (FOLFIRI) useful in the treatment of Colorectal cancer (CRC).
Public/Granted literature
- US20140051642A1 COMPOSITION COMPRISING AFLIBERCEPT, FOLINIC ACID, 5-FLUOROURACIL (5-FU) AND IRINOCETAN (FOLFIRI) Public/Granted day:2014-02-20
Information query
IPC分类:
